Acquired qnrVC1 and blaNDM-1 resistance markers in an international high-risk Pseudomonas aeruginosa ST773 clone.


Journal

Journal of medical microbiology
ISSN: 1473-5644
Titre abrégé: J Med Microbiol
Pays: England
ID NLM: 0224131

Informations de publication

Date de publication:
Mar 2019
Historique:
pubmed: 23 1 2019
medline: 20 3 2019
entrez: 23 1 2019
Statut: ppublish

Résumé

A multidrug-resistant Pseudomonas aeruginosa PS1 isolated from urine clinical sample was investigated in this study. The strain exhibited resistance to piperacillin/tazobactam, ciprofloxacin, imipenem, ceftazidime but it was susceptible to colistin. Analysis of whole-genome sequencing data by ResFinder detected various resistance determinants including qnrVC1 and blaNDM-1. The multiresistant P. aeruginosa isolate belonged to ST773 high-risk clone. The qnrVC1 and blaNDM-1 determinants were incorporated into different integrons. Expression of blaNDM-1 was fourfold and qnrVC1 was twofold increased, compared to that of rpsL housekeeping gene. Mutations in gyrA Thr83Leu and parC Ser87Leu were detected and additionally qnrVC1 expression indicates protective effect of QnrVC1 pentapeptid protein on gyrase and topoisomerase. High-risk P. aeruginosa clones integrate various carbapenemase and other resistance determinants into their genomes that facilitates further dissemination of multiresistance among clinical isolates. We report blaNDM-1 and qnrVC1 genes in P. aeruginosa ST773 international high-risk clone.

Identifiants

pubmed: 30667355
doi: 10.1099/jmm.0.000927
doi:

Substances chimiques

Anti-Bacterial Agents 0
Fluoroquinolones 0
Ciprofloxacin 5E8K9I0O4U
Ceftazidime 9M416Z9QNR
beta-Lactamases EC 3.5.2.6
beta-lactamase NDM-1 EC 3.5.2.6

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

336-338

Auteurs

Bela Kocsis (B)

1 Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary.

Akos Toth (A)

2 National Public Health Institute, Budapest, Hungary.

Daniel Gulyas (D)

1 Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary.

Balazs Ligeti (B)

1 Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary.
3 Faculty of Information Technology and Bionics, Pázmány Péter Catholic University, Budapest, Hungary.

Katalin Katona (K)

4 Department of Microbiology, State Health Center, Budapest, Hungary.

Laszlo Rokusz (L)

5 First Department of Medicine, State Health Center, Budapest, Hungary.

Dora Szabo (D)

1 Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH